EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Proteins and metabolites fingerprints of gestational diabetes mellitus forming protein–metabolite interactomes are its potential biomarkers

Bhaswati Chatterjee, Suman S Thakur

PROTEOMICS · 2023-07 · 23 (13-14)

DOI: 10.1002/pmic.202200257 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PROTEOMICS, online erschienen am 24.03.2023. Verfasst von Bhaswati Chatterjee und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Pharmaceutical Education and Research, Hyderabad, India. Hauptthemen laut MEDLINE: Diabetes, Gestational. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 124 Literaturangaben. Gefördert von: Department of Science and Technology (DST) India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational diabetes mellitus (GDM) is a consequence of glucose intolerance with an inadequate production of insulin that happens during pregnancy and leads to adverse health consequences for both mother and fetus. GDM patients are at higher risk for preeclampsia, and developing diabetes mellitus type 2 in later life, while the child born to GDM mothers are more prone to macrosomia, and hypoglycemia. The universally accepted diagnostic criteria for GDM are lacking, therefore there is a need for a diagnosis of GDM that can identify GDM at its early stage (first trimester). We have reviewed the literature on proteins and metabolites fingerprints of GDM. Further, we have performed protein–protein, metabolite–metabolite, and protein–metabolite interaction network studies on GDM proteins and metabolites fingerprints. Notably, some proteins and metabolites fingerprints are forming strong interaction networks at high confidence scores. Therefore, we have suggested that those proteins and metabolites that are forming protein–metabolite interactomes are the potential biomarkers of GDM. The protein–metabolite biomarkers interactome may help in a deep understanding of the prognosis, pathogenesis of GDM, and also detection of GDM. The protein–metabolites interactome may be further applied in planning future therapeutic strategies to promote long‐term health benefits in GDM mothers and their children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalPregnancyFemaleChildHumansBiomarkersPrognosis

Stichwörter der Autor:innen

biomarkersgestational diabetes mellitus (GDM)interaction networkmetabolitesproteins

Substanzen

Biomarkers

Autor:innen und Institutionen

  • National Institute of Pharmaceutical Education and Research, Hyderabad, India.
  • National Institute of Animal Biotechnology (NIAB), Hyderabad, India.
  • Centre for Cellular and Molecular Biology, Hyderabad, India.

Förderung

  • Department of Science and Technology (DST) India

Zitieren

APA

Chatterjee, B., & Thakur, S. S. (2023). Proteins and metabolites fingerprints of gestational diabetes mellitus forming protein–metabolite interactomes are its potential biomarkers. PROTEOMICS, 23(13-14). https://doi.org/10.1002/pmic.202200257

Vancouver

Chatterjee B, Thakur SS. Proteins and metabolites fingerprints of gestational diabetes mellitus forming protein–metabolite interactomes are its potential biomarkers. PROTEOMICS. 2023;23(13-14). doi:10.1002/pmic.202200257

BibTeX
@article{Chatterjee2023,
  author = {Chatterjee, Bhaswati and Thakur, Suman S},
  title = {Proteins and metabolites fingerprints of gestational diabetes mellitus forming protein–metabolite interactomes are its potential biomarkers},
  journal = {PROTEOMICS},
  year = {2023},
  volume = {23},
  number = {13-14},
  doi = {10.1002/pmic.202200257}
}
Kostenlos starten →